共 50 条
- [41] Efficacy of Rifaximin on Bowel Movement Urgency in Patients with Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D): A Pooled Analysis of 3 Phase 3 Trials AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S253 - S254
- [43] Symptoms of irritable bowel syndrome are common in patients in remission from Inflammatory Bowel Disease: Results from an observational population-based cohort study in Norway JOURNAL OF CROHNS & COLITIS, 2024, 18 : I2042 - I2042
- [44] Effects of probiotic supplementation on abdominal pain severity in pediatric patients with irritable bowel syndrome: a systematic review and meta-analysis of randomized clinical trials World Journal of Pediatrics, 2022, 18 : 320 - 332
- [46] Rifaximin for Improving Abdominal Pain and Bloating Symptoms in Patients With Irritable Bowel Syndrome With Diarrhea (IBS-D) Using Modified Definitions of Pain Response AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S263 - S263
- [47] Rifaximin for improving abdominal pain and bloating symptoms in patients with irritable bowel syndrome with diarrhea (IBS-D) using modified definitions of pain response NEUROGASTROENTEROLOGY AND MOTILITY, 2019, 31
- [49] Metagenomic analysis of intestinal microbiota and mycobiota among diarrhea-predominant irritable bowel syndrome patients from Argentina NEUROGASTROENTEROLOGY AND MOTILITY, 2019, 31